TY - JOUR
T1 - Qualitative and quantitative modifications of von willebrand factor in patients with essential thrombocythemia and controlled platelet count
AU - Lancellotti, Stefano
AU - Dragani, A.
AU - Ranalli, P.
AU - Petrucci, Giovanna
AU - Basso, Maria
AU - Tartaglione, Raffaele
AU - Rocca, Bianca
AU - De Cristofaro, Raimondo
PY - 2015
Y1 - 2015
N2 - Essential thrombocythemia (ET) is characterized by increased platelets and prevalent thrombosis. An acquired Von Willebrand factor (VWF) disease has been hypothesized and inconsistently associated with extreme thrombocytosis or rare bleedings in ET. Whether VWF is modified in ET patients with controlled platelet count remains unclear.
AB - Essential thrombocythemia (ET) is characterized by increased platelets and prevalent thrombosis. An acquired Von Willebrand factor (VWF) disease has been hypothesized and inconsistently associated with extreme thrombocytosis or rare bleedings in ET. Whether VWF is modified in ET patients with controlled platelet count remains unclear.
KW - ADAMTS13 protein, human
KW - Essential Thrombocythemia
KW - Glycocalicin
KW - Platelet Membrane Glycoprotein V
KW - Von Willebrand Factor
KW - ADAMTS13 protein, human
KW - Essential Thrombocythemia
KW - Glycocalicin
KW - Platelet Membrane Glycoprotein V
KW - Von Willebrand Factor
UR - http://hdl.handle.net/10807/66073
U2 - 10.1111/jth.12967
DO - 10.1111/jth.12967
M3 - Article
SN - 1538-7933
VL - 13
SP - 1226
EP - 1237
JO - Journal of Thrombosis and Haemostasis
JF - Journal of Thrombosis and Haemostasis
ER -